Advanced Wound Care Market by Product (Infection Management, Exudate Management, Active Wound Care, and Therapy Devices), Application (Chronic Wounds and Acute Wounds), and End User (Hospitals and Community Health Service Centers): Global Opportunity Analysis and Industry Forecast, 2021–2030
- ALL4676826
- 287 Pages
- September 2021
- Diagnostic and Biotech
The wound healing process can be facilitated in two different ways, including traditional wound care (TWC) and advanced wound care (AWC). Chronic wounds take more time to heal and are expensive to treat. Thus, advanced wound care is developing as a standard solution for treating chronic wounds. Moreover, traditional wound care products such as hydrocolloids, hydrogels, film & foam dressings, and alginates are being increasingly replaced with advanced wound care products, due to their enhanced efficiency & effectiveness in managing wounds by enabling rapid healing.
Moreover, they offer various advantages such as they help maintain a hydrated environment for appropriate flow of oxygen, keep temperature consistent, protect the wound site from exogenous infection, and ease pain associated with dressing changes.
Significant increase in prevalence of chronic diseases such as diabetes & obesity, rise in geriatric population, technological advancements in advanced wound care products, problems associated with traditional wound healing methods, and surge in adoption of evidence-based treatments such as silver dressings, hyperbaric oxygen, electrotherapy, and ultrasound for chronic wounds are the key factors that fuel the growth of the advanced wound care market.
Moreover, surge in awareness programs for advanced wound care treatment & management, attempts to reduce the duration of the hospital stay to lower healthcare expenses, and rise in inclination toward wound care products that enhance therapeutic outcomes are other factors that contribute toward the growth of the market. However, high cost associated with advanced wound care products are expected to hinder the growth of the market.
The advanced wound care market is segmented into product, application, end user, and region. By product, the market is categorized into infection management, exudate management, active wound care, and therapy devices. Infection management is sub segmented into silver dressings, non-silver dressings, and collagens. The exudate management segment is further divided into hydrocolloid dressings, foam dressings, alginate dressings, and hydrogel dressings. The active wound care segment is subdivided into skin substitutes and growth factors. The therapy devices segment is further segmented into negative pressure wound therapy (NPWT), oxygen & hyperbaric oxygen equipment, electromagnetic therapy devices, and others.
The applications covered in the study include chronic wounds and acute wounds. The chronic wounds segment is further segregated into pressure ulcers, diabetic foot ulcers, venous leg ulcers, and arterial ulcers. The acute wounds is further fragmented into burns & trauma, and surgical wounds. Depending on end user, the market is classified into hospitals and community health service centers. On the basis of region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. The major companies profiled in this report include 3M (Acelity Inc.), Adynxx, Inc., B Braun Melsungen AG, Coloplast A/S, ConvaTec Group Plc., Essity AB (BSN Medical GmbH), Integra Lifesciences (Derma sciences), Investor AB (Mölnlycke Health Care AB), Johnson & Johnson, Medline Industries, Inc., Medtronic Plc., Organogenesis Holdings Inc., and Smith & Nephew Plc.
Key benefits for stakeholders
• The study provides an in-depth analysis of the global advanced wound care market along with the current trends and future estimations to elucidate the imminent investment pockets.
• A comprehensive analysis of the factors that drive and restrict the market growth is provided in the report.
• Comprehensive quantitative analysis of the industry from 2021 to 2030 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
• Extensive analysis of the key segments of the industry helps to understand the application and products of advanced wound care used across the globe.
• Key market players and their strategies have been analyzed to understand the competitive outlook of the market.
Key market segments
By Product type
• Infection Management
o Silver Wound Dressings
o Non-silver Dressings
o Collagen Dressings
• Exudate Management
o Hydrocolloids Dressings
o Foam Dressings
o Alginate Dressings
o Hydrogel Dressings
• Active Wound Care
o Skin Substitutes
o Growth Factors
• Therapy Devices
o Negative Pressure Wound Therapy (NPWT)
o Oxygen and Hyperbaric Oxygen Equipment
o Electromagnetic Therapy Devices
o Others
BY APPLICATION
• Chronic Wounds
o Pressure Ulcers
o Diabetic Foot Ulcers
o Venous Leg Ulcers
o Arterial Ulcers
• Acute Wounds
o Burns & Trauma
o Surgical Wounds
BY END USER
• Hospitals
• Community Health Service Centers
BY REGION
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
• Asia-Pacific
o Japan
o China
o Australia
o India
o South Korea
o Rest of Asia-Pacific
• LAMEA
o Brazil
o Saudi Arabia
o South Africa
o Rest of LAMEA
LIST OF KEY PLAYERS PROFILED IN THE REPORT
• 3M (Acelity Inc.)
• Adynxx, Inc.
• B Braun Melsungen AG
• Coloplast A/S
• ConvaTec Group plc
• Essity AB (BSN Medical GmbH)
• Integra Lifesciences (Derma sciences)
• Investor AB (Mölnlycke Health Care AB)
• Johnson & Johnson
• Medline Industries, Inc.
• Medtronic plc.
• Organogenesis Holdings Inc.
• Smith & Nephew Plc.
1.1.Report description
1.2.Key Benefits for Stakeholders
1.3.Key market segments
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.3.Porter’s five force analysis
3.4.Market share analysis
3.4.1.Drivers
3.4.1.1.Rise in geriatric population
3.4.1.2.Upsurge in incidences of diabetes, obesity, and chronic conditions
3.4.1.3.Technological advancements to deal with complex wounds
3.4.2.Restrains
3.4.2.1.High cost of advanced wound care products
3.4.3.Opportunities
3.4.3.1.Untapped opportunities in developing economies
3.5.Market dynamics
3.6.COVID-19 impact on the market
CHAPTER 4:ADVANCED WOUND CARE MARKET, BY PRODUCT
4.1.Overview
4.1.1.Market size and forecast
4.2.Infection management
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.2.4.Market size and forecast, by type
4.2.5.Silver wound dressings
4.2.5.1.Market size and forecast
4.2.6.Non-silver dressings
4.2.6.1.Market size and forecast
4.2.7.Collagen dressings
4.2.7.1.Market size and forecast
4.3.Exudate management
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast
4.3.3.Market analysis, by country
4.3.4.Market size and forecast, by product
4.3.5.Hydrocolloid dressings
4.3.5.1.Market size and forecast
4.3.6.Foam dressings
4.3.6.1.Market size and forecast
4.3.7.Alginate dressings
4.3.7.1.Market size and forecast
4.3.8.Hydrogel dressings
4.3.8.1.Market size and forecast
4.4.Active wound care
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast
4.4.3.Market analysis, by country
4.4.4.Market size and forecast, by type
4.4.5.Skin substitutes
4.4.5.1.Market size and forecast
4.4.6.Growth factors
4.4.6.1.Market size and forecast
4.5.Therapy devices
4.5.1.Key market trends, growth factors, and opportunities
4.5.2.Market size and forecast
4.5.3.Market analysis, by country
4.5.4.Market size and forecast, by type
4.5.5.Negative pressure wound therapy (NPWT)
4.5.5.1.Market size and forecast
4.5.6.Oxygen & hyperbaric oxygen equipment
4.5.6.1.Market size and forecast
4.5.7.Electromagnetic therapy devices
4.5.7.1.Market size and forecast
4.5.8.Others
4.5.8.1.Market size and forecast
CHAPTER 5:ADVANCED WOUND CARE MARKET, BY APPLICATION
5.1.Overview
5.1.1.Market size and forecast
5.2.Chronic wounds
5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country
5.2.3.Market size and forecast, by type
5.2.4.Pressure ulcers
5.2.4.1.Market size and forecast
5.2.5.Diabetic foot ulcers
5.2.5.1.Market size and forecast
5.2.6.Venous leg ulcers
5.2.6.1.Market size and forecast
5.2.7.Arterial ulcers
5.2.7.1.Market size and forecast
5.3.Acute wounds
5.3.1.Market size and forecast
5.3.2.Market analysis, by country
5.3.3.Market size and forecast, by type
5.3.4.Burns & trauma
5.3.4.1.Market size and forecast
5.3.5.Surgical wounds
5.3.5.1.Market size and forecast
CHAPTER 6:ADVANCED WOUND CARE MARKET, BY END USER
6.1.Overview
6.1.1.Market size and forecast
6.2.Hospitals
6.2.1.Market size and forecast
6.2.2.Market analysis, by country
6.3.Community health service centers
6.3.1.Market size and forecast
6.3.2.Market analysis, by country
CHAPTER 7:ADVANCED WOUND CARE MARKET, BY REGION
7.1.Overview
7.1.1.Market size and forecast
7.2.North America
7.2.1.Key market trends, growth factors, and opportunities
7.2.2.Market size and forecast, by country
7.2.2.1.U.S. advanced wound care market, by product
7.2.2.2.U.S. advanced wound care market, by application
7.2.2.3.U.S. advanced wound care market, by end user
7.2.2.4.Mexico advanced wound care market, by product
7.2.2.5.Mexico advanced wound care market, by application
7.2.2.6.Mexico advanced wound care market, by end user
7.2.2.7.Canada advanced wound care market, by product
7.2.2.8.Canada advanced wound care market, by application
7.2.2.9.Canada advanced wound care market, by end user
7.2.3.North America market size and forecast, by product
7.2.4.North America market size and forecast, by application
7.2.5.North America market size and forecast, by end user
7.3.Europe
7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Market size and forecast, by country
7.3.2.1.Germany advanced wound care market, by product
7.3.2.2.Germany advanced wound care market, by application
7.3.2.3.Germany advanced wound care market, by end user
7.3.2.4.UK advanced wound care market, by product
7.3.2.5.UK advanced wound care market, by application
7.3.2.6.UK advanced wound care market, by end user
7.3.2.7.France advanced wound care market, by product
7.3.2.8.France advanced wound care market, by application
7.3.2.9.France advanced wound care market, by end user
7.3.2.10.Italy advanced wound care market, by product
7.3.2.11.Italy advanced wound care market, by application
7.3.2.12.Italy advanced wound care market, by end user
7.3.2.13.Spain advanced wound care market, by product
7.3.2.14.Spain advanced wound care market, by application
7.3.2.15.Spain advanced wound care market, by end user
7.3.2.16.Rest of Europe advanced wound care market, by product
7.3.2.17.Rest of Europe advanced wound care market, by application
7.3.2.18.Rest of Europe advanced wound care market, by end user
7.3.3.Europe market size and forecast, by product
7.3.4.Europe market size and forecast, by application
7.3.5.Europe market size and forecast, by end user
7.4.Asia-Pacific
7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Market size and forecast, by country
7.4.2.1.Japan advanced wound care market, by product
7.4.2.2.Japan advanced wound care market, by application
7.4.2.3.Japan advanced wound care market, by end user
7.4.2.4.China advanced wound care market, by product
7.4.2.5.China advanced wound care market, by application
7.4.2.6.China advanced wound care market, by end user
7.4.2.7.India advanced wound care market, by product
7.4.2.8.India advanced wound care market, by application
7.4.2.9.India advanced wound care market, by end user
7.4.2.10.Rest of Asia-Pacific advanced wound care market, by product
7.4.2.11.Rest of Asia-Pacific advanced wound care market, by application
7.4.2.12.Rest of Asia-Pacific advanced wound care market, by end user
7.4.3.Asia-Pacific market size and forecast, by product
7.4.4.Asia-Pacific market size and forecast, by application
7.4.5.Asia-Pacific market size and forecast, by end user
7.5.LAMEA
7.5.1.Key market trends, growth factors, and opportunities
7.5.2.Market size and forecast, by country
7.5.2.1.Brazil advanced wound care market, by product
7.5.2.2.Brazil advanced wound care market, by application
7.5.2.3.Brazil advanced wound care market, by end user
7.5.2.4.Saudi Arabia advanced wound care market, by product
7.5.2.5.Saudi Arabia advanced wound care market, by application
7.5.2.6.Saudi Arabia advanced wound care market, by end user
7.5.2.7.South Africa advanced wound care market, by product
7.5.2.8.South Africa advanced wound care market, by application
7.5.2.9.South Africa advanced wound care market, by end user
7.5.2.10.Rest of LAMEA advanced wound care market, by product
7.5.2.11.Rest of LAMEA advanced wound care market, by application
7.5.2.12.Rest of LAMEA advanced wound care market, by end user
7.5.3.LAMEA market size and forecast, by product
7.5.4.LAMEA market size and forecast, by application
7.5.5.LAMEA market size and forecast, by end user
CHAPTER 8:COMPANY PROFILES
8.1.3M (ACELITY INC.)
8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.1.5.Business performance
8.1.6.Key strategic moves and developments
8.2.ADYNXX, INC.
8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product portfolio
8.2.5.Key strategic moves and developments
8.3.B. BRAUN MELSUNGEN AG
8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.3.5.Business performance
8.4.COLOPLAST A/S
8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.4.5.Business performance
8.5.CONVATEC GROUP PLC.
8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio
8.5.5.Business performance
8.6.ESSITY AB (BSN MEDICAL GMBH)
8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio
8.6.5.Business performance
8.6.6.Key strategic moves and developments
8.7.INTEGRA LIFESCIENCES HOLDINGS CORPORATION (DERMA SCIENCES)
8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio
8.7.5.Business performance
8.7.6.Key strategic moves and developments
8.8.INVESTOR AB (MÖLNLYCKE HEALTH CARE AB)
8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio
8.8.5.Business performance
8.8.6.Key strategic moves and developments
8.9.JOHNSON & JOHNSON
8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio
8.9.5.Business performance
8.10.MEDLINE INDUSTRIES, INC.
8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio
8.11.MEDTRONIC PLC.
8.11.1.Company overview
8.11.2.Company snapshot
8.11.3.Operating business segments
8.11.4.Product portfolio
8.11.5.Business performance
8.12.ORGANOGENESIS HOLDINGS INC.
8.12.1.Company overview
8.12.2.Company snapshot
8.12.3.Operating business segments
8.12.4.Product portfolio
8.12.5.Business performance
8.13.SMITH & NEPHEW PLC.
8.13.1.Company overview
8.13.2.Company snapshot
8.13.3.Operating business segments
8.13.4.Product portfolio
8.13.5.Business performance
TABLE 01.GLOBAL INCIDENCES OF DIABETES, 2011 VS. 2030 (IN MILLION)
TABLE 02.GLOBAL ADVANCED WOUND CARE MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 03.INFECTION MANAGEMENT ADVANCED WOUND CARE MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 04.INFECTION MANAGEMENT ADVANCED WOUND CARE MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 05.EXUDATE MANAGEMENT ADVANCED WOUND CARE MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 06.EXUDATE MANAGEMENT ADVANCED WOUND CARE MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 07.ACTIVE WOUND CARE MARKET FOR ACTIVE WOUND CARE, BY REGION, 2020–2030 ($MILLION)
TABLE 08.ACTIVE WOUND CARE MARKET ADVANCED WOUND CARE, BY TYPE, 2020–2030 ($MILLION)
TABLE 09.THERAPY DEVICES ADVANCED WOUND CARE MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 10.THERAPY DEVICES ADVANCED WOUND CARE MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 11.GLOBAL ADVANCED WOUND CARE MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 12.CHRONIC WOUND CARE MARKET, BY REGION, 2018–2027 ($MILLION)
TABLE 13.CHRONIC WOUND CARE MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 14.PRESSURE ULCER-RELATED PRODUCTS AND MANUFACTURERS
TABLE 15.CLINICAL TRIALS 1 – PRESSURE ULCERS
TABLE 16.CLINICAL TRIALS 2 - PRESSURE ULCERS
TABLE 17.CLINICAL TRIALS 1 - DIABETIC FOOT ULCERS
TABLE 18.CLINICAL TRIALS 2 - DIABETIC FOOT ULCERS
TABLE 19.CLINICAL TRIALS 1 – VENOUS LEG ULCERS
TABLE 20.CLINICAL TRIALS 2 - VENOUS LEG ULCERS
TABLE 21.CLINICAL TRIALS – ARTERIAL ULCERS
TABLE 22.ACUTE WOUND CARE MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 23.ACUTE WOUND CARE MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 24.GLOBAL ADVANCED WOUND CARE MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 25.ADVANCED WOUND CARE MARKET FOR HOSPITALS, BY REGION, 2020–2030 ($MILLION)
TABLE 26.ADVANCED WOUND CARE MARKET FOR COMMUNITY HEALTH SERVICE CENTERS MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 27.ADVANCED WOUND CARE MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 28.NORTH AMERICA ADVANCED WOUND CARE MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 29.U.S. ADVANCED WOUND CARE MARKET, BY PRODUCT, 2020-2030
TABLE 30.U.S. ADVANCED WOUND CARE MARKET, BY APPLICATION, 2020–2030
TABLE 31.U.S. ADVANCED WOUND CARE MARKET, BY END USER, 2020-2030147
TABLE 32.MEXICO ADVANCED WOUND CARE MARKET, BY PRODUCT, 2020–2030
TABLE 33.MEXICO ADVANCED WOUND CARE MARKET, BY APPLICATION, 2020-2030
TABLE 34.MEXICO ADVANCED WOUND CARE MARKET, BY END USER, 2020-2030
TABLE 35.CANADA ADVANCED WOUND CARE MARKET, BY PRODUCT, 2020–2030
TABLE 36.CANADA ADVANCED WOUND CARE MARKET, BY APPLICATION, 2020-2030
TABLE 37.CANADA ADVANCED WOUND CARE MARKET, BY END USER, 2020-2030
TABLE 38.NORTH AMERICA ADVANCED WOUND CARE MARKET, BY PRODUCT, 2020–2030
TABLE 39.NORTH AMERICA ADVANCED WOUND CARE MARKET, BY APPLICATION, 2020–2030
TABLE 40.NORTH AMERICA ADVANCED WOUND CARE MARKET, BY END USER, 2020-2030
TABLE 41.EUROPE ADVANCED WOUND CARE MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 42.GERMANY ADVANCED WOUND CARE MARKET, BY PRODUCT, 2020–2030
TABLE 43.GERMANY ADVANCED WOUND CARE MARKET, BY APPLICATION, 2020-2030
TABLE 44.GERMANY ADVANCED WOUND CARE MARKET, BY END USER, 2020–2030
TABLE 45.UK ADVANCED WOUND CARE MARKET, BY PRODUCT, 2020-2030
TABLE 46.UK ADVANCED WOUND CARE MARKET, BY APPLICATION, 2020-2030
TABLE 47.UK ADVANCED WOUND CARE MARKET, BY END USER, 2020-2030
TABLE 48.FRANCE ADVANCED WOUND CARE MARKET, BY PRODUCT, 2020–2030
TABLE 49.FRANCE ADVANCED WOUND CARE MARKET, BY APPLICATION, 2020-2030
TABLE 50.FRANCE ADVANCED WOUND CARE MARKET, BY END USER, 2020–2030
TABLE 51.ITALY ADVANCED WOUND CARE MARKET, BY PRODUCT, 2020–2030169
TABLE 52.ITALY ADVANCED WOUND CARE MARKET, BY APPLICATION, 2020-2030
TABLE 53.ITALY ADVANCED WOUND CARE MARKET, BY END USER, 2020-2030
TABLE 54.SPAIN ADVANCED WOUND CARE MARKET, BY PRODUCT, 2020-2030
TABLE 55.SPAIN ADVANCED WOUND CARE MARKET, BY APPLICATION, 2020–2030
TABLE 56.SPAIN ADVANCED WOUND CARE MARKET, BY END USER, 2020–2030
TABLE 57.REST OF EUROPE ADVANCED WOUND CARE MARKET, BY PRODUCT, 2020–2030
TABLE 58.REST OF EUROPE ADVANCED WOUND CARE MARKET, BY APPLICATION, 2020-2030
TABLE 59.REST OF EUROPE ADVANCED WOUND CARE MARKET, BY END USER, 2020–2030
TABLE 60.EUROPE ADVANCED WOUND CARE MARKET, BY PRODUCT, 2020–2030
TABLE 61.EUROPE ADVANCED WOUND CARE MARKET, BY APPLICATION, 2020–2030
TABLE 62.EUROPE ADVANCED WOUND CARE MARKET, BY END USER, 2020–2030
TABLE 63.ASIA-PACIFIC ADVANCED WOUND CARE MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 64.JAPAN ADVANCED WOUND CARE MARKET, BY PRODUCT, 2020-2030
TABLE 65.JAPAN ADVANCED WOUND CARE MARKET, BY APPLICATION, 2020-2030
TABLE 66.JAPAN ADVANCED WOUND CARE MARKET, BY END USER, 2020-2030
TABLE 67.CHINA ADVANCED WOUND CARE MARKET, BY PRODUCT, 2020–2030189
TABLE 68.CHINA ADVANCED WOUND CARE MARKET, BY APPLICATION, 2020–2030
TABLE 69.CHINA ADVANCED WOUND CARE MARKET, BY END USER, 2020–2030
TABLE 70.INDIA ADVANCED WOUND CARE MARKET, BY PRODUCT, 2020-2030
TABLE 71.INDIA ADVANCED WOUND CARE MARKET, BY APPLICATION, 2020-2030
TABLE 72.INDIA ADVANCED WOUND CARE MARKET, BY END USER, 2020-2030
TABLE 73.REST OF ASIA-PACIFIC ADVANCED WOUND CARE MARKET, BY PRODUCT, 2020–2030
TABLE 74.REST OF ASIA-PACIFIC ADVANCED WOUND CARE MARKET, BY APPLICATION, 2020–2030
TABLE 75.REST OF ASIA-PACIFIC ADVANCED WOUND CARE MARKET, BY END USER, 2020-2030
TABLE 76.ASIA-PACIFIC ADVANCED WOUND CARE MARKET, BY PRODUCT, 2020-2030
TABLE 77.ASIA-PACIFIC ADVANCED WOUND CARE MARKET, BY APPLICATION, 2020-2030
TABLE 78.ASIA-PACIFIC ADVANCED WOUND CARE MARKET, BY END USER, 2020-2030
TABLE 79.LAMEA ADVANCED WOUND CARE MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 80.BRAZIL ADVANCED WOUND CARE MARKET, BY PRODUCT, 2020-2030
TABLE 81.BRAZIL ADVANCED WOUND CARE MARKET, BY APPLICATION, 2020-2030
TABLE 82.BRAZIL ADVANCED WOUND CARE MARKET, BY END USER, 2020-2030
TABLE 83.SAUDI ARABIA ADVANCED WOUND CARE MARKET, BY PRODUCT, 2020-2030
TABLE 84.SAUDI ARABIA ADVANCED WOUND CARE MARKET, BY APPLICATION, 2020-2030
TABLE 85.SAUDI ARABIA ADVANCED WOUND CARE MARKET, BY END USER, 2020-2030
TABLE 86.SOUTH AFRICA ADVANCED WOUND CARE MARKET, BY PRODUCT, 2020-2030
TABLE 87.SOUTH AFRICA ADVANCED WOUND CARE MARKET, BY APPLICATION, 2020-2030
TABLE 88.SOUTH AFRICA ADVANCED WOUND CARE MARKET, BY END USER, 2020-2030
TABLE 89.REST OF LAMEA ADVANCED WOUND CARE MARKET, BY PRODUCT, 2020-2030
TABLE 90.REST OF LAMEA ADVANCED WOUND CARE MARKET, BY APPLICATION, 2020-2030
TABLE 91.REST OF LAMEA ADVANCED WOUND CARE MARKET, BY END USER, 2020-2030
TABLE 92.LAMEA ADVANCED WOUND CARE MARKET, BY PRODUCT, 2020-2030217
TABLE 93.LAMEA ADVANCED WOUND CARE MARKET, BY APPLICATION, 2020-2030
TABLE 94.LAMEA ADVANCED WOUND CARE MARKET, BY END USER, 2020-2030
TABLE 95.3M: COMPANY SNAPSHOT
TABLE 96.3M: OPERATING SEGMENTS
TABLE 97.3M: PRODUCT PORTFOLIO
TABLE 98.ADYNXX: COMPANY SNAPSHOT
TABLE 99.ADYNXX: PRODUCT PORTFOLIO
TABLE 100.B. BRAUN: COMPANY SNAPSHOT
TABLE 101.B. BRAUN: OPERATING SEGMENTS
TABLE 102.B BRAUN: PRODUCT PORTFOLIO
TABLE 103.COLOPLAST: COMPANY SNAPSHOT
TABLE 104.COLOPLAST: OPERATING SEGMENTS
TABLE 105.COLOPLAST: PRODUCT PORTFOLIO
TABLE 106.CONVATEC: COMPANY SNAPSHOT
TABLE 107.CONVATEC: OPERATING SEGMENTS
TABLE 108.CONVATEC: PRODUCT PORTFOLIO
TABLE 109.ESSITY: COMPANY SNAPSHOT
TABLE 110.ESSITY: OPERATING SEGMENTS
TABLE 111.ESSITY: PRODUCT PORTFOLIO
TABLE 112.INTEGRA LIFESCIENCES: COMPANY SNAPSHOT
TABLE 113.INTEGRA LIFESCIENCES: OPERATING SEGMENTS
TABLE 114.INTEGRA LIFESCIENCES: PRODUCT PORTFOLIO
TABLE 115.INVESTOR: COMPANY SNAPSHOT
TABLE 116.INVESTOR: OPERATING SEGMENTS
TABLE 117.INVESTOR: PRODUCT PORTFOLIO
TABLE 118.J&J: COMPANY SNAPSHOT
TABLE 119.J&J: OPERATING SEGMENTS
TABLE 120.J&J: PRODUCT PORTFOLIO
TABLE 121.MEDLINE: COMPANY SNAPSHOT
TABLE 122.MEDLINE: OPERATING SEGMENTS
TABLE 123.MEDLINE: PRODUCT PORTFOLIO
TABLE 124.MEDTRONIC: COMPANY SNAPSHOT
TABLE 125.MEDTRONIC: OPERATING SEGMENTS
TABLE 126.MEDTRONIC: PRODUCT PORTFOLIO
TABLE 127.ORGANOGENESIS: COMPANY SNAPSHOT
TABLE 128.ORGANOGENESIS: OPERATING SEGMENTS
TABLE 129.ORGANOGENESIS: PRODUCT PORTFOLIO
TABLE 130.SMITH & NEPHEW: COMPANY SNAPSHOT
TABLE 131.SMITH & NEPHEW: OPERATING SEGMENTS
TABLE 132.SMITH & NEPHEW: PRODUCT PORTFOLIO
Similar Reports
Biomaterials are materials of either synthetic or natural origin that are used for interaction with biological systems for medical purposes such as treating or repairing damage tissues. They are used in joint replacements, plastic surgeries, drug delivery devi...
- Publish Date: September 1, 2016
- $5370
The global DNA sequencing market was estimated to be $6,243 million in 2017 and is projected to reach $25,470 million in 2025 growing with a CAGR of 19% from 2018 to 2025. DNA sequencing is a type of technology in which several DNA strands can be sequenced through massive parallelization. The DNA sequencing contains both Sanger’s method of sequencing and non-Sanger’s methods of sequencing. ...
- Publish Date: May 24, 2017
- $5370
Patients with serious nervous system injuries or strokes often require lifelong assistance, which burdens patients, their families, and society. Innovative, paradigm shifting strategies are required to develop treatments for neurological injury. Early dia...
- Publish Date: May 24, 2017
- $5370
